IRIS UniCatt

Santoro, Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.429
AS - Asia 2.373
EU - Europa 1.686
SA - Sud America 699
AF - Africa 88
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.282
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.319
SG - Singapore 1.165
BR - Brasile 570
CN - Cina 477
IT - Italia 448
SE - Svezia 369
VN - Vietnam 196
DE - Germania 185
IN - India 149
FR - Francia 127
IE - Irlanda 119
FI - Finlandia 90
ID - Indonesia 90
GB - Regno Unito 86
RU - Federazione Russa 64
HK - Hong Kong 47
AR - Argentina 46
CA - Canada 44
MX - Messico 44
NL - Olanda 44
BD - Bangladesh 40
KR - Corea 32
EC - Ecuador 28
CI - Costa d'Avorio 26
IQ - Iraq 23
JP - Giappone 23
PL - Polonia 23
ES - Italia 21
UA - Ucraina 21
AT - Austria 20
PK - Pakistan 19
TR - Turchia 19
ZA - Sudafrica 18
VE - Venezuela 13
SA - Arabia Saudita 12
IR - Iran 11
LT - Lituania 11
BE - Belgio 10
CH - Svizzera 10
CO - Colombia 10
UZ - Uzbekistan 10
CL - Cile 9
EG - Egitto 9
KE - Kenya 9
PY - Paraguay 9
JO - Giordania 8
MA - Marocco 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
UY - Uruguay 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
KZ - Kazakistan 5
TN - Tunisia 5
TW - Taiwan 5
HN - Honduras 4
PE - Perù 4
PH - Filippine 4
PT - Portogallo 4
AL - Albania 3
BO - Bolivia 3
DZ - Algeria 3
IL - Israele 3
JM - Giamaica 3
NP - Nepal 3
PA - Panama 3
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GH - Ghana 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
Totale 7.268
Salva come PNG Salva come JPEG
Città #
Singapore 565
Chandler 459
Ashburn 291
Beijing 140
Dallas 138
Rome 123
Dublin 114
New York 100
Los Angeles 91
Ho Chi Minh City 89
Hyderabad 87
Hefei 86
Jakarta 78
Milan 66
The Dalles 61
Boston 58
São Paulo 57
Princeton 51
Munich 47
Frankfurt am Main 45
Hong Kong 45
San Mateo 41
Hanoi 39
Moscow 38
Helsinki 34
Marseille 30
Seoul 29
Wilmington 29
Lappeenranta 27
Turku 27
Abidjan 26
Fairfield 25
Kent 21
Santa Clara 19
Brooklyn 18
Falkenstein 18
Tokyo 18
Brasília 17
Houston 17
Rio de Janeiro 17
Warsaw 17
Atlanta 16
Buffalo 16
Chicago 16
Montreal 15
Belo Horizonte 14
Denver 14
Düsseldorf 14
London 14
Redwood City 14
Mexico City 13
Augusta 12
Guayaquil 12
Bremen 11
Curitiba 11
Hải Dương 11
Nanjing 11
Norwalk 11
Nuremberg 11
Orem 11
Palermo 11
Seattle 11
Stockholm 11
Baghdad 10
Brussels 10
Chennai 10
Dhaka 10
Phoenix 10
Ann Arbor 9
Busto Arsizio 9
Johannesburg 9
Naaldwijk 9
Querétaro 9
Salt Lake City 9
Washington 9
Amman 8
Bologna 8
Cattolica 8
Dearborn 8
Jacksonville 8
Kish 8
Lauterbourg 8
Loreto 8
Manchester 8
Paris 8
Poplar 8
Tashkent 8
Toronto 8
Vienna 8
Woodbridge 8
Bexley 7
Council Bluffs 7
Da Nang 7
Mumbai 7
Portsmouth 7
Quito 7
Roubaix 7
Santo André 7
Vancouver 7
Baku 6
Totale 3.880
Salva come PNG Salva come JPEG
Nome #
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 172
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 172
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making 123
Reduction mammoplasty using oxidized regenerated cellulose as a filler in breast conservation surgery 123
Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group 121
Radial Scar: a management dilemma 117
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 114
Mesonephric-like adenocarcinoma of the endometrium: detailed molecular characterization of the first case showing a morphological continuum from mesonephric-like metaplasia and atypical mesonephric-like hyperplasia to adenocarcinoma 111
Histopathological evaluation of tumor-infiltrating lymphocytes (TILs) as predictive biomarker for hormone receptors status, proliferative activity and clinical outcome in her-2 positive breast cancer 111
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 108
Assessing Post-Treatment Pathologic Tumor Response in Female Genital Tract Carcinomas: An Update 107
OncotypeDX (R) predictive nomogram for recurrence score output: A machine learning system based on quantitative immunochemistry analysis-ADAPTED01 104
Myofibroblastoma of the breast: two case reports and literature review 102
Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature 102
Granular Cell Tumor of the Breast: Clinical Presentation, Pathological Diagnosis and Treatment 101
Neuroendocrine Carcinoma of the Uterine Cervix: A Clinicopathologic and Immunohistochemical Study with Focus on Novel Markers (Sst2-Sst5) 98
The vulvar immunohistochemical panel (Vip) project: Molecular profiles of vulvar squamous cell carcinoma 97
Identification of a minimum number of genes to predict triple-negative breast cancer subgroups from gene expression profiles 95
Clinico-pathological significance of TCGA classification and SWI/SNF proteins expression in undifferentiated/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification 95
SATB2 is expressed in neuroendocrine carcinoma of the uterine cervix 94
Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease 91
Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer 90
“Clock mapping” prior to excisional surgery in vulvar Paget’s disease: tailoring the surgical plan 90
When a mimicker wears strange faces: Description of an osteogenic melanoma arising within an ovarian teratoma with focus on its late peritoneal relapse 89
Endometrial Metaplastic/Reactive Changes Coexistent with Endometrial Hyperplasia and Carcinoma: A Morphological and Immunohistochemical Study 89
Pathological features, immunoprofile and mismatch repair protein expression status in uterine endometrioid carcinoma: focus on MELF pattern of myoinvasion 87
Melanocyte Colonization and Pigmentation of Breast Carcinoma: Description of Two Pathological Cases and Review of Literature 87
Low-grade myofibroblastic sarcoma of the breast 86
An Emerging Anti-p16 Antibody-BC42 Clone as an Alternative to the Current E6H4 for Use in the Female Genital Tract Pathological Diagnosis: Our Experience and a Review on p16ink4a Functional Significance, Role in Daily-Practice Diagnosis, Prognostic Potential, and Technical Pitfalls 86
Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications 86
Recent Advances in Cervical Cancer Management: A Review on Novel Prognostic Factors in Primary and Recurrent Tumors 85
Corded and hyalinized endometrioid endometrial carcinoma with high-grade features: a clinicopathological and TCGA-based molecular analysis 85
Acral melanoma of the hallux 85
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience 84
Clear cell carcinoma of the endometrium: an immunohistochemical and molecular analysis of 45 cases 84
Postchemotherapy Endometrioid to Gastrointestinal Histotype Shift in Recurrent Endometrial Carcinoma 84
New pathological and clinical insights in endometrial cancer in view of the updated esgo/estro/esp guidelines 83
Hemangioma of the umbilical cord with associated amnionic inclusion cyst: two uncommon entities occurring simultaneously 83
Incidence, malignancy rates of diagnoses and cyto-histological correlations in the new Italian Reporting System for Thyroid Cytology: An institutional experience. 82
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: Our experience 82
Prognostic Value of Chemotherapy Response Score (CRS) Assessed on the Adnexa in Ovarian High-Grade Serous Carcinoma: A Systematic Review and Meta-Analysis 82
Pilomatrix-like High-Grade Endometrioid Carcinoma of the Ovary: Case Report, Literature Review, and Differential Diagnosis 81
Peritoneal Carcinomatosis from Yolk Sac Tumor in a Postmenopausal Woman Following Chemotherapy for High-grade Ovarian Serous Carcinoma 81
A new entity in the pathological spectrum of vulvar neoplasms: The first report of a primary endometrioid adenocarcinoma 81
The Many Faces of Endometriosis-Related Neoplasms in the Same Patient: A Brief Report 81
Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer 81
Ovarian endometrioid carcinoma with a sex cord-like pattern: a morphological, immunohistochemical, and molecular analysis 80
Role of Retinoblastoma Protein Family (Rb/p105 and Rb2/p130) Expression in the Histopathological Classification of Borderline Ovarian Tumors 80
Diagnostic and Prognostic Role of WT1 Immunohistochemical Expression in Uterine Carcinoma: A Systematic Review and Meta-Analysis across All Endometrial Carcinoma Histotypes 80
Endometrial giant cell carcinoma: new insights from a morphological, immunohistochemical, and molecular analysis of three cases 80
Prognostic Value of Mandard’s Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer 77
The multiple facets of ovarian high grade serous carcinoma: A review on morphological, immunohistochemical and molecular features 77
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score–matched analysis 75
The vulvar immunohistochemical panel (VIP) project: molecular profiles of vulvar Paget's disease 74
Ultrasound-guided FNA cytology of groin lymph nodes improves the management of squamous cell carcinoma of the vulva: Results from a comparative cytohistological study 74
Evaluation of Beta-Catenin Subcellular Localization and Water Channel Protein AQP1 Expression as Predictive Markers of Chemo-Resistance in Ovarian High-Grade Serous Carcinoma: Comparative Study between Preoperative Peritoneal Biopsies and Surgical Samples 74
Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience 73
Tamoxifen related Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT): A case report and literature review of this possible association 73
Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports 73
Endometrial carcinomas with dyshesive, eosinophilic, and vacuolated (histiocyte-like) tumor cells: a reactive-like phenotype associated with aggressive behavior 73
Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs 72
The Role of Plasma Cells as a Marker of Chronic Endometritis: A Systematic Review and Meta-Analysis 72
Retrospective study of histopathological and prognostic characteristics of primary fallopian tube carcinomas: twenty-year experience (SOCRATE) 72
The emerging and challenging role of PD-L1 in patients with gynecological cancers: An updating review with clinico-pathological considerations 70
Morphological and immunohistochemical evaluation in distinguishing post-radiotherapy serous-like endometrial change (PoRSEC) and serous endometrial intraepithelial carcinoma (SEIC) 68
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 68
Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis 68
TCGA molecular subgroups of endometrial carcinoma in ovarian endometrioid carcinoma: A quantitative systematic review 67
L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma 67
Ganglioglioma arising in an ovarian teratoma 67
Aberrant non-canonical WNT pathway as key-driver of high-grade serous ovarian cancer development 66
Prognostic significance of atypical mitotic figures in smooth muscle tumors of uncertain malignant potential (STUMP) of the uterus and uterine adnexa 66
Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes Tumors 66
Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer 64
Breast Cancer Orbital Metastases: Clinical and Histopathological Characteristics, Imaging Features, and Disease-Related Survival in a Multicentric Retrospective Case Series 64
Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomas 64
Chemotherapy Response Score (CRS): A comprehensive review of its prognostic and predictive value in High-Grade Serous Carcinoma (HGSC) 63
Neuroendocrine tumors of the submandibular gland: literature review and report of a case 63
TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives 62
Surgery after upfront chemoradiation in locally advanced squamous cell vulvar cancer: Analysis of postoperative outcomes and survival 61
Cerebellar metastasis from ovarian carcinoma harboring PIK3CA-activating mutation: A “clear” explanation for an unexpected “vertigo” 58
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication 51
Methylation Profile of X-Chromosome–Related Genes in Male Breast Cancer 51
The role of cytology in endometrial cancer: Diagnostic and clinical considerations from peritoneal/pelvic washings. Is it still a heated debate? 50
Prognostic value of the TCGA molecular classification in uterine carcinosarcoma 46
Predictive factors of sentinel lymph node failed mapping in endometrial carcinoma patients: A systematic review and meta-analysis 46
Accuracy of One-Step Nucleic Acid Amplification in Detecting Lymph Node Metastases in Endometrial Cancer 46
Ultra-High frequency ultrasound imaging of lymphatic channels correlates with their histological features: A step forward in lymphatic surgery 43
Breast cancer orbital metastases: Clinical, histopathological features and disease related survival in a retrospective case series 43
Beyond the WHO 2020 Classification of Female Genital Tumors: Types of Endometrial Cancer: A Pathological and Molecular Focus on Challenging Rare Variants 42
Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma 37
Integrated histological parameters define prognostically relevant groups in atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia 33
Totale 7.411
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.772
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202188 0 0 0 0 0 7 13 7 7 24 21 9
2021/2022417 16 10 1 41 12 20 13 67 27 18 84 108
2022/20231.184 124 161 93 181 61 156 76 101 133 17 60 21
2023/2024723 25 203 22 32 22 125 41 29 16 45 88 75
2024/20251.806 32 29 128 54 110 75 98 67 209 269 423 312
2025/20263.009 670 197 482 694 806 160 0 0 0 0 0 0
Totale 7.411